Pick Up This Bargain Even Cheaper Than Director Dietz Did
January 23, 2020 at 15:25 PM EST
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on January 10, Eiger BioPharmaceuticals Inc's Director, Thomas John Dietz, invested $55,760.00 into 4,000 shares of EIGR, for a cost per share of $13.94..